![Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet](https://www.thelancet.com/cms/attachment/0c37580c-c143-4f36-88f9-6b0d46ba0da9/gr1_lrg.jpg)
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet
![New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? - ScienceDirect New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021915020315872-gr3.jpg)
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? - ScienceDirect
![Forest plot for triglycerides (mg/dL) change from baseline to 12 months... | Download Scientific Diagram Forest plot for triglycerides (mg/dL) change from baseline to 12 months... | Download Scientific Diagram](https://www.researchgate.net/publication/275672725/figure/fig3/AS:392025196253212@1470477498975/Forest-plot-for-triglycerides-mg-dL-change-from-baseline-to-12-months-in-weight-loss.png)
Forest plot for triglycerides (mg/dL) change from baseline to 12 months... | Download Scientific Diagram
![2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders 2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders](https://www.archivesofmedicalscience.com/f/fulltexts/127582/AMS-16-2-39975-g002.jpg)
2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders
![Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention | Arteriosclerosis, Thrombosis, and Vascular Biology Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/5dec3d36-d45a-49f7-a7c1-a943a24f3470/255ga1.jpg)